Wonderful review on HES vs. EGPA by Dr. Amy Klion ⭐️1st line tx still steroids ⭐️New ACR 2021 EGPA guidelines ⭐️ANCA status can affect EGPA tx response ⭐️mepolizumab useful for EGPA and HES ⭐️ongoing trial for benralizumab (anti-IL-5R) #ACR21 @RheumNow https://t.co/Xr99nAx5BA